These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

123 related articles for article (PubMed ID: 23587604)

  • 1. A novel method for calculating prevalence of multiple sclerosis in Australia.
    Palmer AJ; Hitchens PL; Simpson S; O'Leary B; Colman S; Taylor BV
    Mult Scler; 2013 Nov; 19(13):1704-11. PubMed ID: 23587604
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Pharmacoepidemiology and the Australian regional prevalence of multiple sclerosis.
    Hollingworth S; Walker K; Page A; Eadie M
    Mult Scler; 2013 Nov; 19(13):1712-6. PubMed ID: 23530000
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Change in multiple sclerosis prevalence over time in Australia 2010-2017 utilising disease-modifying therapy prescription data.
    Campbell JA; Simpson S; Ahmad H; Taylor BV; van der Mei I; Palmer AJ
    Mult Scler; 2020 Oct; 26(11):1315-1328. PubMed ID: 31347952
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The economic impact of multiple sclerosis in Australia in 2010.
    Palmer AJ; Colman S; O'Leary B; Taylor BV; Simmons RD
    Mult Scler; 2013 Oct; 19(12):1640-6. PubMed ID: 23652216
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Vitamin D levels in people with multiple sclerosis and community controls in Tasmania, Australia.
    van der Mei IA; Ponsonby AL; Dwyer T; Blizzard L; Taylor BV; Kilpatrick T; Butzkueven H; McMichael AJ
    J Neurol; 2007 May; 254(5):581-90. PubMed ID: 17426912
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Assessing possible selection bias in a national voluntary MS longitudinal study in Australia.
    Taylor BV; Palmer A; Simpson S; Lucas R; ; Simmons RD; Mason D; Pearson J; Clarke G; Sabel C; Willoughby E; Richardson A; Abernethy D
    Mult Scler; 2013 Oct; 19(12):1627-31. PubMed ID: 23530001
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Alternative data sources for estimating multiple sclerosis prevalence.
    Koch-Henriksen N
    Mult Scler; 2013 Nov; 19(13):1682-3. PubMed ID: 24218485
    [No Abstract]   [Full Text] [Related]  

  • 8. The prevalence and demographic distribution of treated epilepsy: a community-based study in Tasmania, Australia.
    D'Souza WJ; Quinn SJ; Fryer JL; Taylor BV; Ficker DM; O'Brien TJ; Pearce N; Cook MJ
    Acta Neurol Scand; 2012 Feb; 125(2):96-104. PubMed ID: 21355857
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Urban/rural differences in health insurance coverage among people with multiple sclerosis.
    Buchanan RJ; Zhu L; James W
    Disabil Rehabil; 2007 Dec; 29(24):1890-8. PubMed ID: 17852264
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Epidemiology of multiple sclerosis in Australia. With NSW and SA survey results.
    McLeod JG; Hammond SR; Hallpike JF
    Med J Aust; 1994 Feb; 160(3):117-22. PubMed ID: 8295576
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Twenty-year trends in benzodiazepine dispensing in the Australian population.
    Islam MM; Conigrave KM; Day CA; Nguyen Y; Haber PS
    Intern Med J; 2014 Jan; 44(1):57-64. PubMed ID: 24450521
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Chronic heart failure beyond city limits.
    Clark RA; McLennan S; Eckert K; Dawson A; Wilkinson D; Stewart S
    Rural Remote Health; 2005; 5(4):443. PubMed ID: 16359188
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Trends in the epidemiology of multiple sclerosis in Greater Hobart, Tasmania: 1951 to 2009.
    Simpson S; Pittas F; van der Mei I; Blizzard L; Ponsonby AL; Taylor B
    J Neurol Neurosurg Psychiatry; 2011 Feb; 82(2):180-7. PubMed ID: 21097824
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Migration and multiple sclerosis in immigrants from United Kingdom and Ireland to Australia: a reassessment. III: risk of multiple sclerosis in UKI immigrants and Australian-born in Hobart, Tasmania.
    Barnett MH; McLeod JG; Hammond SR; Kurtzke JF
    J Neurol; 2016 Apr; 263(4):792-8. PubMed ID: 26914927
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Regional variation in infant hypoallergenic formula prescriptions in Australia.
    Mullins RJ; Clark S; Camargo CA
    Pediatr Allergy Immunol; 2010 Mar; 21(2 Pt 2):e413-20. PubMed ID: 19943914
    [TBL] [Abstract][Full Text] [Related]  

  • 16. High prevalence of sickness absence and disability pension among multiple sclerosis patients: a nationwide population-based study.
    Tinghög P; Hillert J; Kjeldgård L; Wiberg M; Glaser A; Alexanderson K
    Mult Scler; 2013 Dec; 19(14):1923-30. PubMed ID: 23652218
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The rising prevalence and changing age distribution of multiple sclerosis in Manitoba.
    Marrie RA; Yu N; Blanchard J; Leung S; Elliott L
    Neurology; 2010 Feb; 74(6):465-71. PubMed ID: 20071664
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Familial recurrence risks for multiple sclerosis in Australia.
    O'Gorman C; Freeman S; Taylor BV; Butzkueven H; ; Broadley SA
    J Neurol Neurosurg Psychiatry; 2011 Dec; 82(12):1351-4. PubMed ID: 21551470
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The use of disease-modifying agents among multiple sclerosis patients enrolled in medicare from 1995 to 2002 and the impact of medicare part D: analysis of claims data from the medicare current beneficiary survey.
    Lundy J; Craig BM
    Clin Ther; 2006 Jan; 28(1):140-5. PubMed ID: 16490588
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Prevalence of multiple sclerosis in Korea.
    Kim NH; Kim HJ; Cheong HK; Kim BJ; Lee KH; Kim EH; Kim EA; Kim S; Park MS; Yoon WT;
    Neurology; 2010 Oct; 75(16):1432-8. PubMed ID: 20956788
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.